Chlorhexidine Mucoadhesive Buccal Tablets: The Impact of Formulation Design on Drug Delivery and Release Kinetics Using Conventional and Novel Dissolution Methods
Oropharyngeal candidiasis (OPC) is a mucosal infection caused by <i>Candida</i> spp., and it is common among the immunocompromised. This condition is mainly treated using oral antifungals. Chlorhexidine (CHD) is a fungicidal and is available as a mouth wash and oral gel. It is used as an...
Main Authors: | Enas Al-Ani, David Hill, Khalid Doudin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/6/493 |
Similar Items
-
Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac
by: Santosh Koirala, et al.
Published: (2021-03-01) -
Mucoadhesive Gels Designed for the Controlled Release of Chlorhexidine in the Oral Cavity
by: Adamo Fini, et al.
Published: (2011-09-01) -
Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation
by: Çelik B
Published: (2017-11-01) -
Development of an ANN optimized mucoadhesive buccal tablet containing flurbiprofen and lidocaine for dental pain
by: Hussain Amjad, et al.
Published: (2016-06-01) -
Effects of Sucrose Palmitate on the Physico-Chemical and Mucoadhesive Properties of Buccal Films
by: András Kelemen, et al.
Published: (2020-11-01)